Brian Bares
Bares Capital Management
Bares Capital Management Globus Medical stake
total: 156
Bares Capital Management GMED trades
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2025 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q3
According to 2025 Q3 report, Bares Capital Management holds 521,129 Globus Medical (GMED) shares with a market value of roughly $29.85M accounting for 2.75% of the overall portfolio. To date, the estimated cost basis is nearly $57.27 for "buy" trades. Bares Capital Management first purchased GMED in 2025 Q3, initially acquiring 521,129 shares.
When did Bares Capital Management buy Globus Medical (GMED)?
Bares Capital Management first invested in Globus Medical (GMED) in 2025 Q3 at the reported quarter-end price of $57.27 per share.
What's the cost basis of Bares Capital Management's GMED stake?
The estimated cost basis for Globus Medical (GMED) stake is around $57.27 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $57.27
Bares Capital Management's historical trades in Globus Medical
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
2.75%
|
521,129
|
$57.27
|
$29,845,058
|
new
|
+2.75%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.